Adapting To Change: New Focused Review in Circulation Explores The Relationship Between Weight Reduction and Muscle Health

Contributed by: Business Wire

Images

MRI-based muscle assessment - Determining the relationship between drug-induced weight reduction and muscle health (Photo: Business Wire)
MRI-based muscle assessment - Determining the relationship between drug-induced weight reduction and muscle health (Photo: Business Wire)
Business Wire embedded0

Tags

Diabetes
Health Technology
Radiology
Pharmaceutical
Surgery
Professional Services
Medical Devices
Hospitals
Fitness & Nutrition
Clinical Trials
Cardiology
Biotechnology
Science
Data Analytics
Research
Health
AMRA Medical

More Like This

Credit: Collaboration with Dr. Ian J Neeland, University Hospitals Cleveland. Data from NCT03038620 (ClinicalTrials.gov identifier) analysed with AMRA® Researcher

AMRA Medical’s Muscle Composition Analysis Used to Evaluate the Effect of Liraglutide Treatment in Obesity

AMRA Medical's Personalized Fat Z-scores (Photo: Business Wire)

AMRA Medical’s Innovative Fat Z-Score Biomarkers Show Tirzepatide Treatment is Associated with a Potential Targeted Effect on Visceral Fat and Liver Fat

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol (Photo: Business Wire)

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

PR Newswire associated0

Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

PR Newswire associated0

GLP-1 DRUG LIRAGLUTIDE MAY PROTECT AGAINST DEMENTIA

PR Newswire associated0

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

PR Newswire associated0

Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association's 84th Scientific Sessions

AMRA® Profiler 4 provides rapid and precise body composition measurements in relation to normative data, contextualizing insights at the individual patient level, with high accuracy. (Graphic: Business Wire)

AMRA Medical Secures European Medical Device Regulation Certificate for AMRA® Profiler 4, Highlighting Yet Another Regulatory Win